Market revenue in 2023 | USD 372.3 million |
Market revenue in 2030 | USD 700.8 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Anti-vegf agents |
Fastest growing segment | Anti-VEGF agents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma |
Key market players worldwide | Pfizer Inc, Alcon Inc, Novartis AG ADR, Bausch Health Companies Inc, Merck & Co Inc, Regeneron Pharmaceuticals Inc, AbbVie Inc, Bayer AG, Genentech, Nicox SA Share from reverse split, Coherus BioSciences Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.
Anti-vegf agents was the largest segment with a revenue share of 32.82% in 2023. Horizon Databook has segmented the Mexico ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-inflammatory, anti-glaucoma covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico has a high rate of dry eye disease coupled with the growth of the country's biotechnology and biopharmaceutical industries, owing to the increasing number of startups and rising investments. These factors are expected to contribute to market growth.
In addition, several organizations in the country are creating awareness related to eye care, which is boosting market growth. For instance, the Mexican Society of Ophthalmology provides eye care education to the general public, indirectly offering treatment options for retinal disorders.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico ophthalmic drugs market , including forecasts for subscribers. This country databook contains high-level insights into Mexico ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account